MedPath

MAR-TERIFLUNOMIDE

MAR-TERIFLUNOMIDE

Approved
DIN Number

02500469

Drug Class

Human

Market Date

May 18, 2022

Company
HC

marcan pharmaceuticals inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02500469
AIG Number0154970001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AK02 TERIFLUNOMIDE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification90:04.20
Health Canada Classification

ACTIVE INGREDIENTS (1)

TERIFLUNOMIDEActive
Strength: 14 MG
Monograph: TERIFLUNOMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.